Alexandria — Full Portfolio
6 tracked investments · listed companies and verified rows first
Congruence Therapeutics is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to identify new medicines.
AI & Machine LearningBiotechDeep Tech
Clarissa Desjardins(Founder)
Co-investorsOrbiMedDIMENSIONBDC Thrive Venture Fund for WomenLumira Ventures
Applied Therapeutics is a biopharmaceutical company developing treatments for rare diseases, with a portfolio focused on Classical Galactosemia and CMT-SORD.
BiotechHealthtechNew York, US
Shoshana Shendelman(Executive Officer, Director)
BoardLes Funtleyder(Director)
Board seatJoel S. Marcus· per SEC Form D · $20M raise · filed Nov 2019
Co-investorsEvolution VC Partners
BiotechWoburn, US
David Lucchino(Executive Officer, Director)Christopher R. Loose(Executive Officer)
BoardRobert Langer(Director)Marc Kozin(Director)Marc Cohen(Director)Timothy Barberich(Director)
Board seatJoel S. Marcus· per SEC Form D · $42.3M raise · filed Jul 2020
Co-investorsvenBio PartnersKendall Capital Partners
BiotechTucson, US
Louis Breton(Executive Officer, Director)David Baltimore, Ph.D.(Director)Bhavin Raval(Executive Officer)
BoardPeter Kolchinsky(Director)inJon Faiz Kayyem, Ph.D.(Director)Harry A. George(Director)
Co-investorsCycad Group LLCRA Capital
Hoofprint Biome develops probiotics and natural enzymes based on microbiome engineering to reduce methane emissions from cattle while improving animal health and feed yield.
AgTechBiotechClimate TechCary, US
Scott Collins(Director)Kathryn Polkoff(Executive Officer, Director)
BoardRodolphe Barrangou(Director)
Co-investorsGood Growth CapitalSOSV
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.